Although the research deal between Scripps Research Institute and Sandoz Pharmaceuticals Corp. generated a great deal of negative publicity this year, it is a fact of life that all non-profit organizations must worry about maintaining a stable funding base.
For the La Jolla Cancer Research Foundation, part of the solution is to pursue a long-term strategy to decrease its dependence on NIH grants by retaining an ownership position in the companies it starts.
LJCRF's motivation to reduce the NIH relationship is that reliance on grant funding makes it difficult to manage the foundation's research operations, President and CEO Erkki Ruoslahti told BioCentury. The competition for grants is "ferocious," he said, and grant monies are targeted, so if the foundation loses a grant in a particular area, it has to lay